These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20709544)

  • 1. Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor.
    Yang L; Xu X; Huang Y; Zhang B; Zeng C; He H; Wang C; Hu L
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5469-71. PubMed ID: 20709544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
    Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
    Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
    Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C
    Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
    Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
    Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors.
    Langford HM; Williams PD; Homnick CF; Vacca JP; Felock PJ; Stillmock KA; Witmer MV; Hazuda DJ; Gabryelski LJ; Schleif WA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):721-5. PubMed ID: 18078751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrazide-containing inhibitors of HIV-1 integrase.
    Zhao H; Neamati N; Sunder S; Hong H; Wang S; Milne GW; Pommier Y; Burke TR
    J Med Chem; 1997 Mar; 40(6):937-41. PubMed ID: 9083482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel furocoumarins as potential HIV-1 integrase inhibitors.
    Olomola TO; Mosebi S; Klein R; Traut-Johnstone T; Coates J; Hewer R; Kaye PT
    Bioorg Chem; 2014 Dec; 57():1-4. PubMed ID: 25159595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferrocenyl chalcone difluoridoborates inhibit HIV-1 integrase and display low activity towards cancer and endothelial cells.
    Monserrat JP; Al-Safi RI; Tiwari KN; Quentin L; Chabot GG; Vessières A; Jaouen G; Neamati N; Hillard EA
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6195-7. PubMed ID: 21889342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and anti-integrase activity of catechol-DKA hybrids.
    Maurin C; Bailly F; Mbemba G; Mouscadet JF; Cotelle P
    Bioorg Med Chem; 2006 May; 14(9):2978-84. PubMed ID: 16412645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates--a new class of HIV-1 integrase inhibitors.
    Donghi M; Kinzel OD; Summa V
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1930-4. PubMed ID: 19269170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
    De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A
    Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
    Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
    J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
    Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.
    Li H; Wang C; Sanchez T; Tan Y; Jiang C; Neamati N; Zhao G
    Bioorg Med Chem; 2009 Apr; 17(7):2913-9. PubMed ID: 19269185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New 2-arylnaphthalenediols and triol inhibitors of HIV-1 integrase--discovery of a new polyhydroxylated antiviral agent.
    Maurin C; Lion C; Bailly F; Touati N; Vezin H; Mbemba G; Mouscadet JF; Debyser Z; Witvrouw M; Cotelle P
    Bioorg Med Chem; 2010 Jul; 18(14):5194-201. PubMed ID: 20541944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.